Epclusa — Medical Mutual

Initial criteria

• Patient is age ≥ 3 years
• Patient does not have cirrhosis OR has compensated cirrhosis (Child-Pugh A)
• Patient has not been previously treated with sofosbuvir/velpatasvir
• Medication is prescribed by or in consultation with a gastroenterologist, hepatologist, infectious diseases physician, or a liver transplant physician

Approval duration

12 weeks